Advanced search
Publication Cover
Blood Pressure Volume 33, 2024 - Issue 1
Submit an article Journal homepage
537
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?

Sverre E. Kjeldsena Departments of Cardiology and Nephrology, University of Oslo Ullevaal Hospital, Oslo, NorwayCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2389-0272View further author information
ORCID Icon,
Brent M. Eganb American Medical Association, University of SC, Greenville, SC, USAORCID Iconhttps://orcid.org/0000-0002-1470-5875View further author information
ORCID Icon,
Michel Burnierc Faculty of Biology and Medicine, University of Lausanne, Lausanne, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-1283-8487View further author information
ORCID Icon,
Krzysztof Narkiewiczd Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolandORCID Iconhttps://orcid.org/0000-0001-5949-5018View further author information
ORCID Icon,
Reinhold Kreutze Institute of Clinical Pharmacology and Toxicology, Charité-University Medicine, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0002-4818-211XView further author information
ORCID Icon &
Giuseppe Manciaf Department of Medicine, University of Milan-Bicocca, Milan, ItalyORCID Iconhttps://orcid.org/0000-0003-0942-3176View further author information
ORCID Icon
Article: 2329571 | Received 24 Jan 2024, Accepted 07 Mar 2024, Published online: 31 Mar 2024

References

  • Mancia G, Kreutz R, Brunström M, et al. ESH guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12)2023:1–3. doi: 10.1097/HJH.0000000000003480.
  • Mancia G, Kjeldsen SE, Kreutz R, et al. Individualized beta-blocker treatment for high blood pressure dictated by medical comorbidities: indications Beyond the 2018 European society of cardiology/European society of hypertension guidelines. Hypertension. 2022;79(6):1153–1166. doi: 10.1161/HYPERTENSIONAHA.122.19020.
  • Esler M, Kjeldsen SE, Pathak A, et al. Diverse pharmacological properties, trial results, comorbidity prescribing, and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. Blood Press. 2022;31(1):210–224. doi: 10.1080/08037051.2022.2110858.
  • Bergland OU, Halvorsen L, Søraas CL, et al. Detection of nonadherence to antihypertensive treatment by measurements of serum drug concentrations. Hypertension. 2021;78(3):617–628. doi: 10.1161/HYPERTENSIONAHA.121.17514.
  • Parati G, Kjeldsen S, Coca A, et al. Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis. Hypertension. 2021;77(2):692–705. doi: 10.1161/HYPERTENSIONAHA.120.15781.
  • Schmieder RE, Wassmann S, Predel HG, et al. Improved persistence to medication, decreased cardiovascular events and reduced all-cause mortality in hypertensive patients with use of single-pill combinations: results from the START-Study. Hypertension. 2023;80(5):1127–1135. doi: 10.1161/HYPERTENSIONAHA.122.20810.
  • Heimark S, Mehlum M, Mancia G, et al. Middle-aged and older patients with left ventricular hypertrophy: higher mortality with drug treated systolic blood pressure below 130 mm hg. Hypertension. 2023;80(8):1739–1748. doi: 10.1161/HYPERTENSIONAHA.123.21454.
  • Okin PM, Hille DA, Kjeldsen SE, et al. Impact of lower achieved blood pressure on outcomes in hypertensive patients. J Hypertens. 2012;30(4):802–810; discussion 810. doi: 10.1097/HJH.0b013e3283516499.
  • Sevre K, Rist A, Wachtell K, et al. The current best drug treatment for hypertensive heart failure with preserved ejection fraction. Eur J Intern Med. 2023;120:3–10. doi: 10.1016/j.ejim.2023.10.008.
  • Kasiakogias A, Rosei EA, Camafort M, et al. Hypertension and heart failure with preserved ejection fraction: position paper by the European society of hypertension. J Hypertens. 2021;39(8):1522–1545. doi: 10.1097/HJH.000000000000291.
  • Kollias A, Kyriakoulis KG, Stambolliu E, et al. Prognostic value of office blood pressure measurement in patients with atrial fibrillation on anticoagulation therapy: systematic ­review and meta-analysis. J Hypertens. 2020;38(1):13–20. doi: 10.1097/HJH.0000000000002244.
  • Kreutz R. The role of blood pressure control in hypertensive patients with atrial fibrillation. J Hypertens Res. 2021;7:1–3.
  • Manolis AJ, Boden WE, Collins P, et al. State of the art approach to managing angina and ischemia: tailoring treatment to the evidence. Eur J Intern Med. 2021;92:40–47. doi: 10.1016/j.ejim.2021.08.003.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.